In the following I will give a short and general overview of the existing gray markets (definition and conditions). Furthermore, I will focus on the pharmaceutical industry which I consider the most interesting, even if dangerous. After a short description of possible gray market activities in this industry within the European Union I will enumerate some of the most important measures and regulations that are being taken against this serious problem. Finally, I will mention the negative as well as possible positive effects of gray markets, on both the producer and the consumer.
“Gray markets are significant as they now exceed $10 billion per year in North America and affect almost every major-trademarked product (Grenier, 1998). Gray markets are growing at more than 22 per cent annually (Lowe and McCrohan, 1988) and expect further growth as export operations increase (Myers, 1999).”
When reading these lines one can presume that gray market activities are an inevitable result of the export of trade marked goods. Since exports are increasing steadily there are several attempts to restrain these semi-illegal activities.
Table of Contents
1. INTRODUCTION
2. GENERAL ASPECTS
A. DEFINITION
B. CONDITIONS FOR THE DEVELOPMENT OF GRAY MARKETS
3. GRAY MARKETS IN PRACTICE
PHARMACEUTICAL GRAY MARKETS
PARALLEL IMPORT OF PHARMACEUTICALS IN THE EUROPEAN UNION
4. LEGAL BACKGROUND VIOLATIONS
A. REGULATION OF PARALLEL TRADE IN THE EUROPEAN COMMUNITY TREATY
B. EUROPEAN COURT OF JUSTICE’S DECISIONS
CONSEQUENCES AND EFFECTS OF THESE ECJ DECISIONS
5. COUNTERMEASURES
6. EFFECTS RESULTING FROM THE EXISTENCE OF GRAY MARKETS
7. EXAMPLES
8. CONCLUSION
Objectives and Topics
This paper examines the phenomenon of gray markets, specifically focusing on the pharmaceutical industry within the European Union, to understand the economic and legal challenges they present to manufacturers and authorized distributors.
- The definition and prerequisite conditions for the emergence of gray markets.
- The legal conflicts between trademark/patent rights and the free movement of goods within the EU.
- The role of the European Court of Justice (ECJ) and the "exhaustion of rights" doctrine.
- The impact of price differentials and logistics on international distribution strategies.
- Paradoxical effects, such as the potential of gray market goods to mitigate the influence of counterfeit products.
Excerpt from the Book
b. Conditions for the development of gray markets
“It appears that the current gray market is caused by a different set of circumstances, primarily over supply - too many goods chasing too few customers.”
But it is not simply a matter of the conditions enabling the development of gray markets. They are a much more complex issue. The background is much wider and has to be described step by step.
“In general, there are three prerequisites for the evolution of gray markets: (1) gray marketers must have a source of supply, (2) trade barriers between countries must be low enough to provide easy access from one market to another, and (3) price differentials must be large enough to appeal to the profit motives of gray marketers.”
As long as there is a source of supply gray market activities will exist and even expand. Authorized distributors will not cease selling products to anyone demanding to buy them, including gray market distributors.
Summary of Chapters
1. INTRODUCTION: Provides an overview of the significance of gray markets in the North American economy and outlines the scope of the paper, specifically the focus on the pharmaceutical industry.
2. GENERAL ASPECTS: Defines gray market products as genuine, legally imported items distributed through unauthorized channels, and identifies the core prerequisites for their development.
3. GRAY MARKETS IN PRACTICE: Discusses the prevalence of gray markets across various industries, narrowing the focus to pharmaceutical parallel imports within the European Union.
4. LEGAL BACKGROUND VIOLATIONS: Analyzes the interplay between EU treaty regulations, patent/trademark law, and the interpretative role of the European Court of Justice in managing parallel trade.
5. COUNTERMEASURES: Explores strategies manufacturers can employ to mitigate gray market activity, emphasizing the complexity of global uniform pricing.
6. EFFECTS RESULTING FROM THE EXISTENCE OF GRAY MARKETS: Evaluates the negative impacts on manufacturer sales and reputation alongside the paradoxical observation that gray markets may pre-empt counterfeit competition.
7. EXAMPLES: Offers real-world illustrations of entities involved in parallel trade and the existence of forums for gray market participants.
8. CONCLUSION: Synthesizes the findings, highlighting the tension between the EU's goal of free movement of goods and the protection of intellectual property rights.
Keywords
Gray market, pharmaceutical industry, parallel import, European Court of Justice, trademark law, patent law, exhaustion of rights, price differentials, distribution channels, counterfeit goods, European Union, intellectual property, innovation reward, supply chain, trade barriers.
Frequently Asked Questions
What is the core subject of this paper?
The paper explores the economic and legal aspects of gray markets, which are defined as the unauthorized distribution of genuine trademarked goods.
What are the primary thematic areas covered?
The research covers definitions, prerequisites for market development, legal conflicts within the EU, pricing strategies, and the specific impact on the pharmaceutical sector.
What is the primary objective of this work?
The objective is to provide a comprehensive overview of why gray markets exist and how legal frameworks, particularly those of the European Union, address the tension between intellectual property rights and market competition.
Which scientific method is used?
The paper utilizes a literature-based analytical approach, reviewing legal precedents from the European Court of Justice and economic theories related to global marketing and distribution strategies.
What does the main body address?
It details the legal environment (Contract, Patent, and Trademark law), evaluates ECJ decisions like the "exhaustion of rights" doctrine, and discusses industry-specific countermeasures for manufacturers.
Which keywords characterize this work?
Key terms include Gray market, pharmaceutical industry, parallel import, exhaustion of rights, trademark law, and the European Union.
How does the "exhaustion of rights" doctrine affect manufacturers?
The doctrine prevents patent holders from controlling the distribution of a product once it has been legally marketed in a member state, thereby limiting their ability to prevent parallel imports within the EU.
Why might gray markets be considered paradoxically beneficial?
The paper suggests that because gray market goods are genuine, they can satisfy market demand and consequently diminish the market share available for lower-quality counterfeit goods.
- Citar trabajo
- Marta Agnieszka Marciniak (Autor), 2002, Crime in Business. Grey market products and EU-legislation, Múnich, GRIN Verlag, https://www.grin.com/document/16102
